bortezomib
SpainDrugs containing this active substance
-
It is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer that affects the lymph nodes) in patients over 18 years of age.
Form: solution for injection
Active substance Dosage bortezomib 2,5 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer that affects the lymph nodes) in adults.
Form: powder for solution for injection
Active substance Dosage bortezomib 3,5 mg Manufacturer: Eugia Pharma (Malta) Limited
-
It is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a cancer that affects the lymph nodes) in adults.
Form: powder for solution for injection
Active substance Dosage bortezomib 3.5 mg Manufacturer: Reddy Pharma Iberia S.A.
-
It is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a cancer that affects the lymph nodes) in adults.
Form: solution for injection
Active substance Dosage bortezomib 2,5 mg/ml Manufacturer: Ever Valinject Gmbh
-
It is used to treat multiple myeloma (a type of bone marrow cancer) in adults, either alone or in combination with other medicines, and also to treat mantle cell lymphoma (a type of lymph node cancer) in combination with other drugs.
Form: powder for solution for injection
Active substance Dosage bortezomib 3,5 mg Manufacturer: Fresenius Kabi Deutschland Gmbh
-
It is used to treat multiple myeloma (a cancer of the bone marrow) in patients over 18 years of age, either alone or in combination with other medicines, and also for the treatment of mantle cell lymphoma in patients aged 18 years or older.
Form: powder for solution for injection
Active substance Dosage bortezomib 3,5 mg Manufacturer: Kern Pharma S.L.
-
It is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a cancer that affects the lymph nodes) in patients over 18 years of age.
Form: solution for injection
Active substance Dosage bortezomib 2,50 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer that affects the lymph nodes).
Form: powder for solution for injection
Active substance Dosage bortezomib 3,5 mg Manufacturer: Sun Pharmaceutical Industries (Europe) B.V.
-
It is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a cancer that affects the lymph nodes) in adults.
Form: powder for solution for injection
Active substance Dosage bortezomib 3,5 mg Manufacturer: Waverley Pharma Europe Limited
-
It is used to treat multiple myeloma (a cancer of the bone marrow) in adults, either alone or in combination with other medicines, and also for the treatment of mantle cell lymphoma (a cancer of the lymph nodes).
Form: powder for solution for injection
Active substance Dosage bortezomib 3,5 mg Manufacturer: Janssen-Cilag International N.V